Back to Journals » OncoTargets and Therapy » Volume 9

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma

Total article views   HTML views PDF downloads Totals
6,898 Dovepress* 6,390+ 1,337 7,727
PubMed Central* 508 192 700
Totals 6,898 1,529 8,427
*Since 25 July 2016

View citations on PubMed Central and Google Scholar